WebJul 26, 2024 · EyeGate is a clinical-stage pharmaceutical company developing and commercializing products for treating inflammatory and immune diseases with a focus on the eye and nervous system. SALT LAKE CITY, UT, November 8, 2024 – Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (“Kiora” or the “Company”) is the new name of EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG). Kiora will trade on the Nasdaq Capital Market under the ticker symbol “KPRX” and CUSIP number 49721T101. The new brand reflects the Company’s aim to not ...
EyeGate Pharma Acquires Jade Therapeutics - Kiora Pharmaceuticals
WebDec 21, 2024 · About EyeGate EyeGate is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products for treating diseases and … WebDec 21, 2024 · EyeGate is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products for treating diseases and disorders of the eye. EyeGate’s lead product, Ocular Bandage Gel (“OBG”), is based on a modified form of the natural polymer hyaluronic acid. hosta icy halo
Global Pan Uveitis Treatment Market Research Report 2024
WebDec 21, 2024 · EyeGate is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products for treating diseases and disorders of the eye. … WebJun 14, 2024 · EyeGate is a clinical-stage pharmaceutical company developing and commercializing products for treating inflammatory and immune diseases with a focus on … WebWALTHAM, Mass., March 07, 2016 — Eyegate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye, today announced that it has acquired Jade Therapeutics, Inc. (“Jade ... psychology department university of akron